DIOPSYS INC

PINE BROOK, NJ · Medtech · Acquired

Visual electrophysiology diagnostic devices that measure electrical responses of the eye and visual pathway to assess retinal and optic nerve function

Claim this profile

Follows are private to you and power your alerts

Updated · diopsys.com

Sector
Medtech
Headquarters
PINE BROOK, NJ
Latest Form D
$1M, Mar 2020
Total capital
$1M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$1M
1 Form D · last Mar 2020
79 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
3
4 pending · first 2016
Rank in peer group#370 of 1112

Capital timeline

2020FEDERAL ↑EQUITY ↓Cumulative $1M1st Form D$1M
2020FEDERAL ↑EQUITY ↓Cumulative $1M1st Form D$1M

Latest events

  • Private capital raisedForm D · SEC · 1st filing$1M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#370 · top 33%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Alan RichExecutive OfficerNamed in SEC Form D filings
  • Bill ShieldsExecutive OfficerNamed in SEC Form D filings
  • Donald LeponeExecutive OfficerNamed in SEC Form D filings
  • Joseph FontanettaExecutive OfficerNamed in SEC Form D filings
  • Matthew EmmerExecutive OfficerNamed in SEC Form D filings
  • Scott KahnExecutive OfficerNamed in SEC Form D filings
Show all 7 people
  • Todd ChristieDirectorNamed in SEC Form D filings

What it has protected

USPTO · 3 granted of 7
Show all 7 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .